Omada Health is trading at $19.48, up 6.47%, in after-hours trading, with no clear company-specific catalyst identified.
- The November 5 third-quarter results announcement was a scheduled-event notice, not the earnings release.
- Shares fell 16.32% in the regular session while supplied major-index figures were nearly flat; available reports did not identify a specific explanation for the move.
- After-hours trading volume was not verified.